Buyer for regulatory affairs consultancy company in Europe

Company to buy

• Size: Medium
• Sales: 10 – 50 million EUR
• Location: Europe
• Reason for acquisition: The management wants to expand their business
• #CFIE PHB193

Overview of buyer for regulatory affairs consultancy company in Europe

The company aids biotechnology and pharmaceutical companies to launch their products with the smoothest possible regulatory submission processes. Further, it offers high-value-added regulatory affairs consultancy services in more than 45 countries worldwide. Now, the company is looking for a suitable acquisition target in Europe.

Profile (strategy) of the buyer for regulatory affairs consultancy company in Europe

Overall, the company’s focus is centered on helping clients in their product development and sales efforts in the biotech and pharmaceutical industries. Additionally, it makes an effort to bring together patients, providers, and regulators in order to optimize regulatory processes and streamline product launches. Moreover, it has offices on three continents and has a strong track record in over 45 countries. Among its clients are top biotech and pharmaceutical companies. Most importantly, the company aids clients in demonstrating the value of their products in development and in their approval and sales process. Above all, it processes hard data and research into strong and impactful insights.

Subscribe as an interested seller
Contact us to get details about this buyer for regulatory affairs consultancy company in Europe

Activities and products of a suitable target

The buyer seeks a target company that is involved in activities and offers products in regulatory affairs consultancy. First, the company must be located in Europe. Ideally, the annual revenue range for the target is between 10 and 50 million euros. Significantly, companies that have a track record and a history in commercialization services, pharmaceutical collaboration, platform services, biopharmaceutical services, agencies, value demonstration services, pharma, and biotech consulting, are highly preferred.

Highlights

High-growth company with an established reputation for excellence
Buyer is in a key strategic position in a growing market, having already established its services globally
Top-notch clientele comprised of large multinational companies in biotech and pharma
Strong cost and revenue synergies available to target company
The buyer is looking into expanding its footprint in European markets

More information on this buyer for regulatory affairs consultancy company in Europe

Please get in touch if you are interested in learning more about this buyer for regulatory affairs consultancy company in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this Pharma buyer

Please use a company e-mail address. No Hotmail/Yahoo/Googlemail etc.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.